Literature DB >> 35300086

Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.

Johannes Karges1, Ryjul W Stokes1, Seth M Cohen1.   

Abstract

Computational modeling of inhibitors for metalloenzymes in virtual drug development campaigns has proven challenging. To overcome this limitation, a technique for predicting the binding pose of metal-binding pharmacophores (MBPs) is presented. Using a combination of density functional theory (DFT) calculations and docking using a genetic algorithm, inhibitor binding was evaluated in silico and compared with inhibitor-enzyme cocrystal structures. The predicted binding poses were found to be consistent with the cocrystal structures. The computational strategy presented represents a useful tool for predicting metalloenzyme-MBP interactions.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35300086      PMCID: PMC8919381          DOI: 10.1021/acsmedchemlett.1c00584

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  63 in total

1.  A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands.

Authors:  Akash Khandelwal; Viera Lukacova; Dogan Comez; Daniel M Kroll; Soumyendu Raha; Stefan Balaz
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

2.  Structure-based design and discovery of potent and selective KDM5 inhibitors.

Authors:  Zhe Nie; Lihong Shi; Chon Lai; Shawn M O'Connell; Jiangchun Xu; Ryan K Stansfield; David J Hosfield; James M Veal; Jeffrey A Stafford
Journal:  Bioorg Med Chem Lett       Date:  2018-03-30       Impact factor: 2.823

3.  Inhibition of histone demethylases by 4-carboxy-2,2'-bipyridyl compounds.

Authors:  Kai-Hsuan Chang; Oliver N F King; Anthony Tumber; Esther C Y Woon; Tom D Heightman; Michael A McDonough; Christopher J Schofield; Nathan R Rose
Journal:  ChemMedChem       Date:  2011-03-15       Impact factor: 3.466

4.  Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  Chem Commun (Camb)       Date:  2012-01-05       Impact factor: 6.222

5.  X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.

Authors:  V Alterio; M Tanc; J Ivanova; R Zalubovskis; I Vozny; S M Monti; A Di Fiore; G De Simone; C T Supuran
Journal:  Org Biomol Chem       Date:  2015-04-07       Impact factor: 3.876

6.  Computation-guided discovery of influenza endonuclease inhibitors.

Authors:  Eric Chen; Robert V Swift; Nazilla Alderson; Victoria A Feher; Gen-Sheng Feng; Rommie E Amaro
Journal:  ACS Med Chem Lett       Date:  2014-01-09       Impact factor: 4.345

7.  Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor.

Authors:  Katherine S England; Anthony Tumber; Tobias Krojer; Giuseppe Scozzafava; Stanley S Ng; Michelle Daniel; Aleksandra Szykowska; KaHing Che; Frank von Delft; Nicola A Burgess-Brown; Akane Kawamura; Christopher J Schofield; Paul E Brennan
Journal:  Medchemcomm       Date:  2014-12-01       Impact factor: 3.597

8.  'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.

Authors:  David P Martin; Patrick G Blachly; Amy R Marts; Tessa M Woodruff; César A F de Oliveira; J Andrew McCammon; David L Tierney; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2014-03-27       Impact factor: 15.419

9.  On the evolution of the quality of macromolecular models in the PDB.

Authors:  Dariusz Brzezinski; Zbigniew Dauter; Wladek Minor; Mariusz Jaskolski
Journal:  FEBS J       Date:  2020-04-20       Impact factor: 5.542

10.  Photorelease of a metal-binding pharmacophore from a Ru(II) polypyridine complex.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  Dalton Trans       Date:  2021-03-02       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.